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all patients at day 7.  Conclusions: Treating traumatic cor-
neal abrasions by pressure patching, a bandage contact lens 
or ointment alone was equal in reducing the abrasion area 
or reducing pain. According to our results the treatment of 
choice for traumatic abrasions may be adapted to the needs 
and preferences of the patient. 
 Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Traumatic corneal abrasion leads to significant mor-
bidity and medical leave. The incidence of these often 
work-related eye injuries has been reported as high as 
15 per 1,000 people per year of which 87% were traumat-
ic corneal abrasions [1] . Similarly, an audit performed in 
2003 showed that traumatic corneal abrasions due to ex-
ternal foreign bodies are among the most common condi-
tions treated in an emergency eye department  [2] .
 General treatment strategies for corneal epithelial de-
fects are either application of topical antibiotics and 
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 Abstract 
 Purpose: To compare three different treatment modalities 
for traumatic corneal abrasions.  Methods: We conducted a 
prospective, randomized, masked, three-arm clinical study 
of patients presenting with superficial corneal foreign bod-
ies. Treatment modalities were: (1) pressure patching with 
ofloxacin ointment (patch group, PG, n = 18), (2) therapeutic 
contact lens with ofloxacin eye drops (contact lens group, 
CLG, n = 20) and (3) ofloxacin ointment alone (ointment 
group, OG, n = 28). Primary outcome measure was the differ-
ence of the mean corneal abrasion area between the three 
groups at 3 different time points (baseline, day 1 and day 7). 
 Results: A total of 66 patients were included in the study 
over a period of 2 years. Mean initial corneal abrasion area 
was 3.6 ± 3.4 mm 2 in the PG, 4.2 ± 4.0 mm 2 in the CLG and 
3.7 ± 3.1 mm 2 in the OG (p = 0.875). Differences in corneal 
abrasion area at any time point were not statistically signifi-
cant (abrasion area decrease from presentation to day 1 was 
3.4 ± 3.3 mm 2 in the PG, 4.1 ± 4.0 mm 2 in the CLG and 3.5 ± 
3.1 mm 2 in the OG, p = 0.789). The epithelium was healed in 
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short-term occlusion with a pressure patch, topical anti-
biotic ointment as a stand-alone therapy or temporary 
use of bandage contact lenses. Pressure patching can lead 
to disadvantages such as loss of binocular vision, discom-
fort from the patch itself and reduced corneal oxygen-
ation  [3] . The advantages of an ophthalmic ointment in 
preference to antibiotic eye drops include a longer con-
tact time of the applied substance on the ocular surface 
and increased lubrication, which shields the epithelial de-
fect from constant friction by the eyelids. An extensive 
Cochrane systematic review by Turner and Rabiu  [4] was 
conducted to determine the effects of eye patching for 
treating corneal abrasions. In their review of studies [5–
15] , they found no evidence for the use of eye patches for 
simple corneal abrasions as they did not improve day 1 
postinjury healing rates nor reduce pain, and were associ-
ated with discomfort [4] . However, they observed that 
many of the studies did not declare a proper randomiza-
tion process and had a high number of dropouts. The ap-
plication of a soft therapeutic contact lens has been con-
sidered in various studies [16–21] , among the first being 
reports from outcomes of treatment of corneal abrasions 
following excimer laser photorefractive keratectomy [16, 
21] . Contact lenses have been associated with a greater 
relief of pain and photophobia as well as vision increase 
compared to ‘traditional’ methods of treatment. 
 The purpose of our study was to compare three differ-
ent treatment modalities for corneal abrasions secondary 
to removal of foreign bodies (i.e. pressure patching, anti-
biotic ointment alone and use of bandage contact lenses) 
with respect to the following: (1) reduction in corneal 
abrasion area after distinct time points, (2) pain relief, (3) 
duration of medical leave, (4) residual corneal opacity 
and (5) use of analgesics  in a prospective randomized 
manner.
 Materials and Methods 
 This single-center, prospective, masked and randomized study 
was conducted at the Department of Ophthalmology, University 
Hospital of Zurich, Switzerland from October 2008 to April 2010. 
The study was approved by the local ethics committee and adhered 
to the tenets of the Declaration of Helsinki. After informed con-
sent had been obtained, all adults ( ≥ 18 years) diagnosed and treat-
ed for a superficial corneal foreign body at the Department of 
Ophthalmology were enrolled in the study. Exclusion criteria were 
the following: infectious keratitis, advanced trauma with stromal 
loss, corneal abnormalities including epithelial, stromal or endo-
thelial dystrophies, chemical trauma, limbal stem cell deficiency, 
use of chronic topical eye medication, collagen vascular disease 
and children (patients under the age of 16). The topical anesthetic 
employed was oxybuprocaine (Oxybuprocaine 0.4% SDU Faure; 
Laboratoires Théa, Clermont-Ferrand, France). After removal of 
the corneal foreign body with a 25-gauge needle (Terumo ® needle 
25G × 5/8 inch; Terumo Medical Products, Tokyo, Japan) and a 
diamond burr (Alcon Grieshaber AG, Schaffhausen, Switzerland) 
by two ophthalmologists (P.B.K. and M.M.) using the exact same 
technique, the patients were randomly assigned to one of the fol-
lowing therapeutic modalities: 
 (1) pressure patch with ofloxacin ointment (Floxal ® Augen-
salbe 3mg/g; Bausch and Lomb, Switzerland) (patch group, PG); 
 (2) contact lens (PureVision ® , Bausch and Lomb) with non-
preserved ofloxacin eye drops 4 times a day (Floxal ® UD Augen-
tropfen, Bausch and Lomb) (contact lens group, CLG);
 (3) ofloxacin ointment 4 times a day (ointment group, OG).
 Allocation to a treatment modality was conducted by a study 
nurse using numbered closed envelopes, randomized prior to the 
study start using www.randomization.com.
 Patients in the PG received a double-firm pressure patch with 
a folded and an unfolded oval gauze taped over the injured eye 
after application of ofloxacin eye ointment. The patch was re-
moved by the study nurse 30 min prior to ophthalmic examina-
tion at the follow-up visit. In the CLG, a therapeutic contact lens 
was inserted and the patients instructed to use ofloxacin eye drops 
4 times a day. The bandage contact lens was removed by the study 
nurse 30 min prior to ophthalmic examination. Participants of 
the OG were instructed to apply ofloxacin ointment 4 times a day. 
The treating ophthalmologists were masked as best as possible to 
the different treatment groups. None of the patients received top-
ical cycloplegics.
 The treatment was continued until complete corneal abrasion 
area reduction (complete reepithelialization or epithelial regen-
eration line) could be observed. The follow-up was daily until com-
plete corneal abrasion area reduction was seen and always 7 days 
after initial presentation.
 The primary outcome measure was the reduction in corneal 
abrasion area (mm 2 ) from the time of the removal of the foreign 
body to 24 h and 1 week later (day 7). Documentation of the cor-
neal abrasion area was performed by photography (magnifica-
tion ×10) using a digital anterior segment camera (Zeiss FF 450 
plus; Carl Zeiss GmbH, Oberkochen, Germany). The corneal 
 abrasion area was documented shortly after corneal foreign body 
removal (<30 min) and at each follow-up visit. Assessment of cor-
neal abrasion area in mm 2 was done by processing the digital pho-
tographs with a measuring tool (Synedra View ® version 2.1.4.15; 
Synedra Information Technologies, Innsbruck, Austria) by two 
different ophthalmologists (M.M. and R.K.).
 An important secondary outcome measure was the amount of 
pain assessed by using the Wong-Baker FACES Pain Rating Scale 
 [22] at different time points. The grading scales used were first de-
scribed by Wong and Baker, assessing pain in children. It may also 
successfully be used in visually impaired adults  [23] . A recent re-
view  [24] analyzed the validity and reliability of different pain mea-
sures including our employed scale and stated that for the assess-
ment of simple changes in pain intensity it was satisfactory. How-
ever, due to the large number of pain assessment tools there is a 
great diversity in dimensions and no international standard for 
pain assessment. We therefore decided to define a difference of 
2  scores in the Wong-Baker FACES Pain Rating Scale as being 
clinically relevant. Patients graded the amount of pain at the initial 
presentation, 3 h after removal of the corneal foreign body and 
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after 24 h. For statistical analysis, the 6 different faces were allo-
cated to the numbers 0, 2, 4, 6, 8 and 10. Pain relief was the differ-
ence between the pain score at presentation and the pain score 
after 3 and after 24 h, respectively. Further secondary outcome 
measures included the duration of medical leave, the presence of 
residual corneal opacities (yes/no) and the use of oral analgesics. 
This information together with past medical and ocular history 
were obtained by using a standardized questionnaire at initial pre-
sentation and at subsequent follow-up visits at days 1 and 7. 
 Safety data assessed included visual acuity (Snellen), the 
amount of conjunctival injection graded from 1 to 4 with a con-
junctival injection score  [25] and the documentation of serious 
adverse events (such as microbial keratitis). For calculation visual 
acuity scores were converted from Snellen to logMAR scale. 
 Statistical Analysis 
 Analysis was performed with SPSS version 18.0 (IBM,  Chicago, 
Ill., USA). The sample size calculation was performed with nQue-
ry Advisor ® 7.0 (Statistical Solutions Ltd., Cork, Ireland) using 
one-way analysis of variance (equal n’s) with a significance level 
(α) of 0.050 and a power of 0.8. Sample size calculation was per-
formed for the primary outcome. With a power of 0.8 and a p val-
ue of 0.05 the sample size was calculated to be approximately 
17 patients per group. We allowed for a loss to follow-up of 1 pa-
tient per group, thus a minimum of 18 patients were recruited for 
each group. Due to the lack of data on corneal abrasion reduction 
differences, a target difference of 2.0 mm 2 /24 h – being considered 
clinically relevant by the authors – was defined. 
 Descriptive statistics with continuous variables are shown as 
mean ± standard deviation. Relative frequencies for discrete vari-
ables were computed. For normally distributed variables, a one-
way ANOVA was applied in order to investigate differences be-
tween the means of continuous variables (i.e. corneal abrasion 
area reduction and pain relief). Post hoc analysis was performed 
with the Scheffé test. Alternatively, the nonparametric Kruskal-
Wallis test was used. Differences between corneal abrasion area 
and pain score at day 0 and day 1/day 7 were calculated. The 95% 
confidence interval (95% CI) for the difference was computed 
with a paired t test. The differences of the mean corneal abrasion 
area reduction and mean decrease of pain score between the treat-
ment groups were assessed with the one-way ANOVA or Kruskal-
Wallis test. In order to investigate associations between two dis-
crete variables, the χ 2 test was applied. The level of significance 
was set at 0.05.
 Results 
 A total of 66 patients with work-related corneal foreign 
bodies were included in the study over a period of 2 years. 
None of the subjects included was identified as having a 
wooden or vegetable material foreign body. Of the total, 
18 subjects were randomly assigned to pressure patch 
with ofloxacin ointment (PG), 20 subjects to contact lens 
with nonpreserved ofloxacin eye drops 4 times a day 
(CLG) and 28 subjects to ofloxacin ointment 4 times a day 
(OG). Three patients (4.5%; 1 PG, 2 OG) did not show up 
for the 1st follow-up visit (day 1) and were excluded from 
further analysis. The dropout rate at the 2nd follow-up 
visit (after 7 days) was 38% (n = 25). The dropouts were 
evenly distributed between the three groups (p = 0.678). 
The average age was 31.5 ± 11.9 years and all patients were 
male. All three groups were equally comparable regarding 
demographics and time to presentation ( table 1 ). 
 The data of the primary and secondary outcome mea-
sures with their corresponding p values of the analysis are 
shown in  table 2 . There was no statistically significant dif-
ference in primary outcome measure (corneal abrasion re-
duction) or in secondary outcome measures between the 
treatment groups. The abrasion area decreased from pre-
sentation to day 1 by 3.4 ± 3.3 mm 2 in the PG, 4.1 ± 4.0 mm 2 
in the CLG and 3.5 ± 3.1 mm 2 in the OG (p = 0.789). The 
epithelium was healed in all patients at day 7. Despite a 
notable range in abrasion areas among our study patients, 
the statistical distribution of the intra- and intergroup siz-
es was homogenous. The 95% CI of the different abrasion 
areas in mm 2 was 2.0213–5.3532 for the PG, 2.2992–6.0418 
for the CLG and 2.4467–4.9251 for the OG.
 Since all included patients displayed complete corneal 
abrasion area reduction (complete reepithelialization or 
epithelial regeneration line) either after day 1 or day 2 
(n = 3), the abrasion area measurements at day 7 were 
 redundant.
 Analysis of the results of pain relief at 3 h showed that 
the PG achieved a statistically significant level of pain 
relief (mean 1.2, 95% CI 0.2–2.1), while patients in the 
CLG and the OG remained without a statistically sig-
nificant decrease in pain (mean 0.8, 95% CI –1.0 to 2.5 
and mean –0.6, 95% CI –1.9 to 0.7, respectively). How-
ever, there was no statistically significant difference 
when the pain relief between the three groups was com-
pared (Kruskal-Wallis test, p = 0.152).
Table 1.  Baseline and demographic information
PG CLG OG p 
value
Subjects (n) 18 20 28
Age 28.7±12.9 29.7±11.8 34.3±11.1 0.217
Gender all male all male all male
Time to presentation, h 27.0±32.8 25.2±35.4 39.5±38.7 0.117
Initial corneal abrasion
area, mm2 3.6±3.4 4.2±4.0 3.7±3.1 0.875
Initial pain score 4.8±1.7 4.8±2.2 3.9±1.5 0.243
 Comparison of the groups was not statistically significant in any baseline 
or demographic finding (p values).
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 The pain score after 24 h was 0.8 ± 1.6 in the PG, 0.9 ± 
1.3 in the CLG and 1.7 ± 2.7 in the OG (one-way ANOVA, 
p = 0.227) corresponding to a pain relief of 4.1 ± 2.0 (95% 
CI 3.0–5.1) in the PG, 4.0 ± 2.4 (95% CI 2.8–5.1) in the 
CLG and 2.2 ± 3.0 (95% CI 0.9–3.4) in the OG 24 h after 
the therapeutic intervention (Kruskal-Wallis test, p = 
0.04). However, the application of post hoc analysis was 
unable to indicate differing groups.
 Oral analgesics were taken by 3 patients in the PG, 
2 patients in CLG and 7 in the OG. Although a greater 
proportion of patients used analgesics in the OG, this 
finding was not statistically significant (χ 2 test, p = 0.316).
 At day 7 the number of patients showing a residual 
corneal opacity was comparable between the three treat-
ment groups (72% in the PG, 82% in the CLG and 78% in 
the OG, p = 0.933).
 Best-corrected Snellen visual acuity at baseline was 
0.9 ± 0.2 in the PG, 1.0 ± 0.2 in the CLG and 1.1 ± 0.3 in 
the OG. Assessment of visual acuity after 1 week showed 
an average of 1.1 ± 0.2 in the PG, 1.1 ± 0.2 in the CLG 
and 1.1 ± 0.2 in the OG (Kruskal-Wallis, p = 0.265). 
There was no statistically significant difference between 
the treatment groups regarding conjunctival injection at 
baseline (χ 2 test, p = 0.312) or day 1 (Kruskal-Wallis test, 
p = 0.660). The mean change in conjunctival injection 
after therapy assessed at day 1 was 0.7 ± 0.9 in the PG, 
0.4 ± 1.2 in the CLG and 0.4 ± 1.2 in the OG (Kruskal-
Wallis, p = 0.660). An increase of either 1 or 2 scores  [25] 
in conjunctival injection was noted in 1 patient in the 
PG, in 4 patients in the CLG and in 7 patients in the OG 
(χ 2 test, p = 0.712). Assessment of conjunctival injection 
after 1 week revealed only 1 patient in the CLG with a 
grade 1 injection; all other subjects showed grade 0. No 
severe adverse events such as infectious keratitis oc-
curred. One patient suffered a second corneal foreign 
body in the same eye at the 1-week follow-up examina-
tion. He was retreated and excluded from the analysis.
 Discussion 
 Our study was able to show for the first time in a pro-
spective, randomized, masked fashion that there is no sta-
tistically or clinically significant difference regarding the 
therapeutic value of the commonly employed treatment 
modalities used for traumatic corneal abrasions, i.e. 
patching, ointment and bandage contact lenses. 
 With respect to our primary outcome measure (corneal 
abrasion area reduction), none of the therapeutic options 
tested were proven to be advantageous. The recently pub-
lished meta-analysis from Turner and Rabiu  [4] found a 
significantly faster healing time in the groups without patch 
(compared to with patch) in the treatment of simple cor-
neal abrasions. When they excluded two quasi-random-
ized studies, the results concurred with our findings. The 
average abrasion area in our study was 3.8 ± 3.5 mm 2 with 
a high homogeneity in all three groups as opposed to aver-
age areas ranging from 1.6 to 23.7 mm 2 in the studies used 
for comparison in the aforementioned review [4] . Since our 
trial was not designed to study very large abrasions or re-
current erosions, the results and recommendations report-
ed here cannot be thoroughly applied for such cases.
Table 2.  Primary and secondary outcome measure
PG CLG OG p value
Primary outcome measure
Corneal abrasion 
reduction, mm2
initial abrasion area 3.6±3.4 4.2±4.0 3.7±3.1 0.875
area reduction at day 1 3.4±3.3 4.1±4.0 3.5±3.1 0.789
Secondary outcome measure
Pain score initial 4.8±1.7 4.8±2.2 3.9±1.5 0.243
after 3 h 3.7±2.4 4.1±3.3 4.5±3.3 0.694
after 24 h 0.8±1.6 0.9±1.3 1.7±2.7 0.227
Medical leave, days 2.0±1.6 1.5±2.1 1.9±2.2 0.553
Residual corneal opacities (%) 72 82 78 0.933
Use of analgesics (n) 3 2 7 0.316
 The table shows data of the corneal abrasion area as mean mm2 ± standard deviation at initial presentation 
and the area reduction after 24 h. The secondary outcome measure was assessed using the Wong-Baker FACES 
Pain Rating Scale.  Comparison of the groups was not statistically significant in any outcome measure (p values).
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 A further important parameter for the evaluation of 
the efficacy of treatment options for corneal abrasions is 
the amount of pain relief achieved by therapy. 
 Since the main argument of applying a bandage con-
tact lens is immediate pain relief with almost no impair-
ment in visual acuity, we set out to analyze the amount 
of pain relief after the short period of 3 h after removal 
of the foreign body. However, we could not find any sta-
tistically significant difference between the three treat-
ment groups concerning this secondary outcome mea-
sure. Between-group comparison did remain without 
statistical significance. Many prior studies investigating 
this topic have tried to assess pain scores. H owever, such 
studies have had similar difficulties reaching statistically 
significant levels, some even with opposite results [12] . 
The study of Arbour et al.  [14] reported a greater pain 
reduction in patients treated by patching as opposed to 
those who had received no patch treatment. However, 
they stated that 48% of their patients had identified the 
patch itself as the main source of discomfort.  
 Subjective pain intensity has been widely studied in the 
field of oncology and postoperative care and can be mea-
sured by visual analog scales and numerical and verbal 
rating scales  [26, 27] . One of the major drawbacks of such 
tools is the high individual variability with the potential 
of biased assessment and low reproducibility  [24, 28–30] , 
such that it is not surprising to find conflicting results in 
studies assessing the pain due to corneal abrasions.
 All further secondary measures assessed (medical 
leave, residual corneal opacity and use of oral analgesics) 
were not significantly different between the treatment 
groups. In our study all treatment modalities proved to 
be safe for the patients since no adverse events were di-
agnosed and the visual acuity was not affected negatively 
by the therapy. Antibiotic prophylaxis was given for all 
treated subjects to avoid postinterventional bacterial ker-
atitis. Conjunctival injection was noted to be slightly in-
creased in the CLG and mildly increased in the OG, 
though this did not reach statistical significance. A pos-
sible cause for increased conjunctival injection could be 
antibiotic toxicity and/or its base (adeps lanae is used for 
the ointment).
 The number of patients allocated to the three groups 
showed differences due to the termination of study sub-
ject recruitment as soon as the minimum group size to 
achieve the predefined power was reached. We performed 
the power analysis again after completion of our study. 
The measured differences in the primary outcome mea-
sure detected in our study would necessitate an estimated 
sample size per group of n = 361 patients to find a statisti-
cally significant difference. However, the costs and time 
to perform such a study would exceed the scientific and 
clinical relevance by far.
 In conclusion, treating traumatic corneal abrasions by 
pressure patching, a bandage contact lens or ointment 
alone was equal in terms of reducing the abrasion area 
and reducing pain. Given these findings, the decision on 
how to treat can be guided entirely by secondary factors 
such as personal preferences of the patient, presumed 
compliance or economic issues. We believe that such a 
result is of significant practical value since it gives the 
treating physician complete liberty to choose the option 
best suited for each individual patient.
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